Clinical Trial Update: Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

View source ↗

Summary

This update covers the SURPASS CVOT trial comparing tirzepatide with dulaglutide or semaglutide for major cardiovascular events in adults with type 2 diabetes. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dulaglutide (dulaglutide)
• Tirzepatide (tirzepatide)
• semaglutide (semaglutide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type 2 Diabetes | Status: ACTIVE_NOT_RECRUITING